Development, And Translation Forum On Drug Discovery
partilhar
bibliografia
formato
Livro
EBook
ordenação
Data Edição
Ranking
-
Innovations In Pharmacy Training And Sustainable Practice To Advance Patient CareNATIONAL ACADEMIES PRESS12-20250,00€
-
Envisioning A Transformed Clinical Trials Enterprise For 2030NATIONAL ACADEMIES PRESS04-20220,00€
-
Drug Research And Development For Adults Across The Older Age SpanNATIONAL ACADEMIES PRESS12-20210,00€
-
Innovation In Drug Research And Development For Prevalent Chronic DiseasesNATIONAL ACADEMIES PRESS12-20210,00€
-
Reflections On Sharing Clinical Trial DataNATIONAL ACADEMIES PRESS10-20200,00€
-
Enhancing Scientific Reproducibility In Biomedical Research Through Transparent ReportingNATIONAL ACADEMIES PRESS04-20200,00€
-
Examining The Impact Of Real-World Evidence On Medical Product DevelopmentNATIONAL ACADEMIES PRESS04-20190,00€
-
Enabling Precision MedicineNATIONAL ACADEMIES PRESS10-20170,00€
-
Real-World Evidence Generation And Evaluation Of TherapeuticsNATIONAL ACADEMIES PRESS07-20170,00€
-
Deriving Drug Discovery Value From Large-Scale Genetic BioresourcesNATIONAL ACADEMIES PRESS11-20160,00€
-
Advancing The Discipline Of Regulatory Science For Medical Product DevelopmentNATIONAL ACADEMIES PRESS07-20160,00€
-
Rapid Medical Countermeasure Response To Infectious DiseasesNATIONAL ACADEMIES PRESS02-20160,00€
-
Financial Incentives To Encourage Development Of Therapies That Address Unmet Medical Needs For Nervous System DisordersNATIONAL ACADEMIES PRESS10-20150,00€
-
Characterizing And Communicating Uncertainty In The Assessment Of Benefits And Risks Of Pharmaceutical ProductsNATIONAL ACADEMIES PRESS12-20140,00€
-
The Global Crisis Of Drug-Resistant Tuberculosis And Leadership Of China And The BricsNATIONAL ACADEMIES PRESS02-20140,00€
-
Large Simple Trials And Knowledge Generation In A Learning Health SystemNATIONAL ACADEMIES PRESS12-20130,00€
-
International Regulatory Harmonization Amid Globalization Of Drug DevelopmentNATIONAL ACADEMIES PRESS10-20130,00€
-
Sharing Clinical Research DataNATIONAL ACADEMIES PRESS05-20130,00€
-
Developing And Strengthening The Global Supply Chain For Second-Line Drugs For Multidrug-Resistant TuberculosisNATIONAL ACADEMIES PRESS02-20130,00€
-
Accelerating The Development Of New Drugs And DiagnosticsNATIONAL ACADEMIES PRESS10-20120,00€
-
Envisioning A Transformed Clinical Trials Enterprise In The United StatesNATIONAL ACADEMIES PRESS09-20120,00€
-
Facing The Reality Of Drug-Resistant Tuberculosis In IndiaNATIONAL ACADEMIES PRESS07-20120,00€
-
Strengthening A Workforce For Innovative Regulatory Science In Therapeutics DevelopmentNATIONAL ACADEMIES PRESS04-20120,00€
-
Public Engagement And Clinical TrialsNATIONAL ACADEMIES PRESS02-20120,00€
-
Advancing Regulatory Science For Medical Countermeasure DevelopmentNATIONAL ACADEMIES PRESS07-20110,00€
-
The New Profile Of Drug-Resistant Tuberculosis In RussiaNATIONAL ACADEMIES PRESS07-20110,00€
-
The Emerging Threat Of Drug-Resistant Tuberculosis In Southern AfricaNATIONAL ACADEMIES PRESS03-20110,00€
-
Building A National Framework For The Establishment Of Regulatory Science For Drug DevelopmentNATIONAL ACADEMIES PRESS02-20110,00€
-
Direct-To-Consumer Genetic TestingNATIONAL ACADEMIES PRESS12-20100,00€
-
Transforming Clinical Research In The United StatesNATIONAL ACADEMIES PRESS10-20100,00€
-
The Public Health Emergency Medical Countermeasures EnterpriseNATIONAL ACADEMIES PRESS06-20100,00€
-
Accelerating The Development Of Biomarkers For Drug SafetyNATIONAL ACADEMIES PRESS07-20090,00€
-
Breakthrough Business ModelsNATIONAL ACADEMIES PRESS02-20090,00€
-
Addressing The Barriers To Pediatric Drug DevelopmentNATIONAL ACADEMIES PRESS08-20080,00€
-
Emerging Safety ScienceNATIONAL ACADEMIES PRESS04-20080,00€
-
Challenges For The FdaNATIONAL ACADEMIES PRESS10-20070,00€
-
Understanding The Benefits And Risks Of PharmaceuticalsNATIONAL ACADEMIES PRESS08-20070,00€
-
Adverse Drug Event ReportingNATIONAL ACADEMIES PRESS04-20070,00€
